EN
HI
Morepen Laboratories Chart
Morepen Laboratories Share Key Metrics
Volume
35.21 L
Market Cap
2796.21 CR
LTQ@LTP
2@49.82
ATP
50.31
Var Margin
23.62 %
Circuit Range
40.83-61.23
Delivery %
35.5 %
Value
17.72 CR
ASM/GSM
No
Market Lot
1
Summary
Morepen Laboratories share price is ₹49.82 as of 19 Jun, 2026. The stock Morepen Laboratories intraday movement has stayed between ₹49.55 and ₹51.35, while on a 52-week basis,Morepen Laboratories price 52 week high is ₹70.50 & its 52 week low is ₹33.05.
In terms of trading activity, Morepen Laboratories has recorded a volume of 3521416 shares, The Morepen Laboratories has a market cap of ₹547953699 CR. The stock’s Average Traded Price (ATP) stands at ₹50.31, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹49.82.
Morepen Laboratories operates within a circuit range of ₹40.83 – ₹61.23, with a Value of ₹17.72 CR. The Delivery Percentage for the day is 35.5%. Additionally, Morepen Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Morepen Laboratories Fundamentals
P/E Ratio
29.47
P/B Ratio
2.24
Div. Yield
0.39
Sector P/E
69.1
Sector P/B
3.04
Sec. Div. Yield
0.53
Morepen Laboratories Resistance and Support
Pivot 51.39
Resistance
First Resistance
52.23
Second Resistance
53.42
Third Resistance
54.26
Support
First Support
50.2
Second Support
49.36
Third Support
48.17
Morepen Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-05-22 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
Morepen Laboratories News
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Morepen Laboratories announced strong Q4 FY26 results with net profit climbing 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. The company also initiated commercial execution of its CDMO program and proposed a 10% dividend for FY26.
May 27 2026 08:25:48
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Morepen Laboratories' Board approved the second addendum to the Business Transfer Agreement (BTA) with subsidiary Morepen Medipath Limited for the slump sale of its Medical Devices business. The transaction is for Rs.197.10 crore, with the revised appointed date for transfer set to April 1, 2026.
May 26 2026 17:56:35
Read More
Morepen Laboratories Management
| Name | Position |
|---|---|
| Sushil Suri | Chairman & Managing Director |
| Sanjay Suri | Whole Time Director |
Morepen Laboratories Similar Stocks
SMS Pharmaceuticals Ltd.
379.50
5.35 (1.43%)
Aarti Drugs Ltd.
371.00
0.85 (0.23%)
Gujarat Themis Biosyn Ltd.
380.70
8.15 (2.19%)
Panacea Biotec Ltd.
537.40
2.55 (0.48%)
Unichem Laboratories Ltd.
449.35
1.05 (0.23%)
Solara Active Pharma Sciences Ltd.
563.45
-4.10 (0.72%)
Dishman Carbogen Amcis Ltd.
169.32
-0.79 (0.46%)
Sai Parenteral's Ltd.
585.00
0.80 (0.14%)
Kwality Pharmaceuticals Ltd.
2441.10
98.50 (4.20%)
Dr Agarwals Eye Hospital Ltd.
4981.50
-62.80 (1.24%)
Morepen Laboratories FAQs
The Buying Price of Morepen Laboratories share is 49.82 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Morepen Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Morepen Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Morepen Laboratories shares is 29.47. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Morepen Laboratories shares is 2.24. Useful to assess the stock's value relative to its book value.
To assess Morepen Laboratories’s valuation compare Sector P/E, P/B which are 69.1 & 3.04 with sector averages, along with growth rates and financial metrics.
The Market Cap of Morepen Laboratories is 2796.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Morepen Laboratories share price is 70.50 & 33.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Morepen Laboratories belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
Invest in MOREPENLAB
Or Download Choice FinX App
Invest in MOREPENLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade